Skip to content

Nurotron cochlear implant clinical trial(6-65years old)

Nurotron cochlear implant clinical trial(6-65years)

Status
Active, not recruiting
Phases
Phase 3
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONB-17013826
Enrollment
Unknown
Registered
2017-12-13
Start date
2009-12-14
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deaf

Interventions

Case series:Nurotron cochlear implant

Sponsors

The Eye and ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 65 Years

Inclusion criteria

Inclusion criteria: post-lingually severe/extremely severe deafened native Mandarin-speaking patients with age of 6-65 year

Exclusion criteria

Exclusion criteria: 1. Allergic to implant materials; 2. Serious inner ear malformation (MONDINI and large vestibular aqueduct syndrome (LVAS) except); 3. Deafness caused by the cochlear lesions; 4. The middle ear infection or tympanic membrane perforation were not healed; 5. In other domestic cochlear clinical trials, or other cochlear implant patients; 6. Mental illness; 7. Patients with other severe diseases, such as heart disease, etc. 8. Abnormal brain structure (such as the brain white matter dysplasia, demyelinating disease, etc.); 9. People with epilepsy; 10. Scar constitution and sensitive physical patients.

Design outcomes

Primary

MeasureTime frame
Speech perception;

Countries

China

Contacts

Public ContactFanglu Chi

The Eye and ENT Hospital of Fudan University

chifanglu@126.com+86 021-64377134-2202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026